Clinical Trial Update: Phase II Study of Hemay005 in Patients With Active Ankylosing Spondylitis [Phase 2]

View source ↗

Summary

Phase II trial of Hemay005 in active ankylosing spondylitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Hemay005

Snippet

Sponsor: Tianjin Hemay Pharmaceutical Co., Ltd | Conditions: Active Ankylosing Spondylitis | Phase 2 | Status: COMPLETED